Amazon could start selling discounted meds to cash payers as soon as the PillPack deal closes

Life Science

Acceleron and Celgene Blood Disease Drug Luspatercept Hits The Mark in Phase III Trial

Life Science

Biogen Increases Ownership in Samsung Bioepis

Life Science

Zai Lab Starts Phase III China Trial of PARP Inhibitor

Life Science

Soligenix, Inc. Prices $8,000,000 Public Offering At The Market

Life Science

Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar

Life Science

China’s First Home-Developed Anti-Cancer Drug Deemed to Hit the Market by Year-End

Life Science

Chinese businesses make US firm’s most-valued companies list

Technology

Akebia and Keryx Merge to Become Leader in Therapies for Chronic Kidney Disease

Life Science

Amazon to Buy Online Pharmacy PillPack

Life Science

Facebook, Google and other tech giants meet with federal regulators to tackle online opioid sales

Life Science

Ligand Receives $47 Million from WuXi Biologics for Expansion of Worldwide OmniAb® Platform License Agreement

Life Science

Wuxi AppTec JV to Proceed With Cell Immunotherapy Trial

Life Science

China-US cooperation combating breast cancer launched

Life Science

Trump says CFIUS can protect U.S. technology from Chinese acquisitions

Others, Technology